Every year on August 31, communities across the country mark International Overdose Awareness Day. It is a day for acknowledging the scale of a crisis that, despite recent signs of progress, still claimed more than 80,000 lives in the United States in 2024 alone. It's a day for the families who are grieving, for the people in recovery who carry the weight of close calls and losses within their own communities, and for the clinicians and support professionals who live in this work every day.
It is also a useful moment to say something that tends to get lost in how overdose is covered and discussed: most overdose deaths do not happen in isolation from mental health. The two crises are not parallel problems. They are, in most cases, the same problem manifesting in two places at once.
National Overdose Awareness Day, observed each year on August 31, is the world's largest annual campaign to raise awareness about overdose, reduce the stigma surrounding drug-related death, and acknowledge the grief of the families and communities left behind. The day began in Melbourne, Australia in 2001 and has since grown into a global movement observed in dozens of countries.
The focus has always been as much about the living as the dead. The campaign calls for evidence-based prevention, better access to treatment, and a shift in how society understands addiction, away from moral failure and toward a more honest accounting of the medical, neurological, and psychological forces involved.
A report published by the CDC analyzing overdose death data from 43 states, found that nearly 22% of persons who died of drug overdose in 2022 had a documented non-substance-related mental health disorder, with depressive disorders the most common at 13%, followed by anxiety disorders at 9% and bipolar disorder at 6%. The same report found that nearly one in four decedents with a mental health diagnosis had a documented recent contact with a healthcare provider, which means there were missed opportunities for intervention that, if seized, might have changed the outcome.
That 22% figure represents diagnosed conditions that were documented in available records. The actual proportion of people who died of overdose while experiencing depression, anxiety, trauma, or other mental health challenges is almost certainly higher. Mental health conditions are underdiagnosed, undertreated, and frequently unacknowledged until something forces the issue.
The bidirectionality of this relationship is well established. Mental health conditions increase the risk of developing a substance use disorder. Substance use disorders worsen existing mental health conditions. Both share underlying neurobiological and environmental risk factors, including trauma exposure, chronic stress, adverse childhood experiences, and disrupted attachment.
One study examining co-occurring opioid use and depressive disorders found that 47% of patients in a medication-assisted treatment clinic had a lifetime diagnosis of depression, and that co-occurring depression was associated with a significantly greater risk of opioid misuse, overdose, and suicide compared to patients with opioid use disorder alone.
Nearly half. In a population already at elevated risk for overdose.
The treatment system is designed, nominally, to address this overlap. The reality is more complicated. Many people cycle through treatment settings that address the substance use or the mental health condition, but not both at the same clinical moment with the same clinical team. The coordination that the research consistently identifies as essential for this population is still, in practice, the exception rather than the rule.
For many people in recovery, August 31 is not an abstract awareness campaign. It is a day connected to real people: friends, fellow patients from treatment programs, family members, people whose names come up in anniversary conversations. The overdose crisis is not distant from the recovery community. It is woven through it.
People in sustained recovery have something that research and public health messaging cannot replicate: credibility with the population most at risk. The visibility of long-term recovery, the simple fact of people living well after addiction, counters the hopelessness that is one of the most dangerous features of both untreated mental illness and active substance use.
Sustained exposure to grief and loss within a recovery community, while a source of meaning and connection for many, can also be a significant stressor. Grief activates the same neurobiological systems that stress-driven relapse research consistently flags as high-risk territory. Honoring the losses of August 31 and protecting one's own recovery are not competing priorities, but they may require intentional planning, especially for people earlier in their own recovery.
The CDC data on mental health diagnoses among overdose decedents is a map of where the system failed to intervene. Nearly one quarter of overdose deaths involving a documented mental health disorder included a recent contact with a healthcare or emergency setting. Someone saw these people. The connection to meaningful, sustained, coordinated support was not made.
What that gap looks like in practice is a person discharged from an emergency department without a warm handoff to mental health care, someone completing a 30-day treatment program without a clinically supervised plan for the weeks immediately after, a family unsure what kind of support their loved one needs and unable to navigate a system that doesn't make it easy to find out.
The recovery support infrastructure that closes those gaps looks like coordinated clinical case management, professional support in the daily environment, and continuity that does not end at discharge.
Overdose risk does not live primarily in clinical settings. It lives in apartments, in cars, in the hours between appointments, in the moments when a person is alone with a level of distress that the tools available to them cannot absorb. Real overdose prevention has to be present in those moments.
Hired Power's Personal Recovery Assistants are trained, credentialed, and clinically supervised professionals who work inside the client's actual daily environment. For clients managing co-occurring mental health and substance use disorders, that daily-environment presence is where the research on overdose risk consistently points as the most underserved intervention window. A PRA can recognize when a client is approaching a clinical crisis, escalate appropriately within a supervised framework, and provide the kind of grounded, real-time support that a weekly appointment cannot replicate.
For clients whose clinical picture requires comprehensive coordination across mental health, addiction, medical, and legal domains, CarePathways Clinical Case Management provides the integrated oversight that the CDC data on missed intervention opportunities points toward. Up to 15 clinical assessments in the first month alone ensures that co-occurring mental health conditions are identified and addressed alongside the substance use, not treated as a separate problem to be managed by a different team at a different time.
If you are supporting a family member in recovery or researching options following a close call or a period of instability, the Hired Power contact team is available around the clock for confidential consultations.
A Note on Resources
If you or someone you love is in crisis, the 988 Suicide and Crisis Lifeline is available by call or text at 988, 24 hours a day. If there is an immediate risk of overdose or harm, call 911.
Additional resources for families and individuals navigating addiction and mental health recovery are available on the Hired Power Recovery Blog.